Stay updated on Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page footer revision tag was updated from v3.6.2 to v3.6.3, indicating a new platform release.
    Difference
    0.0%
    Check dated 2026-07-03T21:53:08.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision: v3.6.2 now appears on the page, replacing Revision: v3.6.0. This reflects a deployment update to the ClinicalTrials.gov interface in the Record History view.
    Difference
    0.0%
    Check dated 2026-06-26T23:19:48.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The history adds that the study is no longer recruiting participants, and notes Revision: v3.6.0, replacing the prior v3.5.5 in the revision history.
    Difference
    0.2%
    Check dated 2026-06-12T14:27:09.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing Revision: v3.5.4. This metadata update indicates the site's revision version is current and does not alter the study history content.
    Difference
    0.0%
    Check dated 2026-06-05T10:37:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's revision label updates from Revision: v3.5.3 to Revision: v3.5.4. This indicates a newer version of the page rendering.
    Difference
    0.0%
    Check dated 2026-05-15T06:13:05.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page’s displayed software/UI revision number from v3.5.2 to v3.5.3. This reflects a platform release rather than a change to the study record itself.
    Difference
    0.0%
    Check dated 2026-04-24T06:33:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in TKI-Resistant EGFR-Mutated NSCLC Clinical Trial page.